世界のバイオ医薬品用前臨床断層撮影システム市場予測（～2028年）：CT、SPECT、その他

• 英文タイトル：Global Preclinical Tomography System for Biopharmaceuticals Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8318 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

バイオ医薬品用前臨床断層撮影システム市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のバイオ医薬品用前臨床断層撮影システムの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 バイオ医薬品用前臨床断層撮影システム市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・CT、SPECT、その他 用途別セグメントは次のように区分されます。 ・病院、研究所、その他 世界のバイオ医薬品用前臨床断層撮影システム市場の主要な市場プレーヤーは以下のとおりです。 ・Bruker、MR Solutions、Scanco Medical、PerkinElmer、Trifoil Imaging、Mediso、Sedecal、MILabs 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、バイオ医薬品用前臨床断層撮影システム製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバイオ医薬品用前臨床断層撮影システムメーカーの企業概要、2019年～2022年までのバイオ医薬品用前臨床断層撮影システムの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバイオ医薬品用前臨床断層撮影システムメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別バイオ医薬品用前臨床断層撮影システムの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのバイオ医薬品用前臨床断層撮影システムの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバイオ医薬品用前臨床断層撮影システム市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびバイオ医薬品用前臨床断層撮影システムの産業チェーンを掲載しています。 ・第13、14、15章では、バイオ医薬品用前臨床断層撮影システムの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bruker、MR Solutions、Scanco Medical、PerkinElmer、Trifoil Imaging、Mediso、Sedecal、MILabs ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：CT、SPECT、その他 ・用途別分析2017年-2028年：病院、研究所、その他 ・バイオ医薬品用前臨床断層撮影システムの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・バイオ医薬品用前臨床断層撮影システムのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオ医薬品用前臨床断層撮影システムのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオ医薬品用前臨床断層撮影システムの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・バイオ医薬品用前臨床断層撮影システムの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Preclinical Tomography System for Biopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preclinical Tomography System for Biopharmaceuticals market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Preclinical Tomography System for Biopharmaceuticals global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CT segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Preclinical Tomography System for Biopharmaceuticals include Bruker, MR Solutions, Scanco Medical, PerkinElmer, and Trifoil Imaging, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preclinical Tomography System for Biopharmaceuticals market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CT
SPECT
Others
Market segment by Application can be divided into
Hospital
Research Institute
Other
The key market players for global Preclinical Tomography System for Biopharmaceuticals market are listed below:
Bruker
MR Solutions
Scanco Medical
PerkinElmer
Trifoil Imaging
Mediso
Sedecal
MILabs
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preclinical Tomography System for Biopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Preclinical Tomography System for Biopharmaceuticals, with price, sales, revenue and global market share of Preclinical Tomography System for Biopharmaceuticals from 2019 to 2022.
Chapter 3, the Preclinical Tomography System for Biopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preclinical Tomography System for Biopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Preclinical Tomography System for Biopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preclinical Tomography System for Biopharmaceuticals.
Chapter 13, 14, and 15, to describe Preclinical Tomography System for Biopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Preclinical Tomography System for Biopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 CT
1.2.3 SPECT
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Global Preclinical Tomography System for Biopharmaceuticals Market Size & Forecast
1.4.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume (2017-2028)
1.4.3 Global Preclinical Tomography System for Biopharmaceuticals Price (2017-2028)
1.5 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity Analysis
1.5.1 Global Preclinical Tomography System for Biopharmaceuticals Total Production Capacity (2017-2028)
1.5.2 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Preclinical Tomography System for Biopharmaceuticals Market Drivers
1.6.2 Preclinical Tomography System for Biopharmaceuticals Market Restraints
1.6.3 Preclinical Tomography System for Biopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bruker
2.1.1 Bruker Details
2.1.2 Bruker Major Business
2.1.3 Bruker Preclinical Tomography System for Biopharmaceuticals Product and Services
2.1.4 Bruker Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 MR Solutions
2.2.1 MR Solutions Details
2.2.2 MR Solutions Major Business
2.2.3 MR Solutions Preclinical Tomography System for Biopharmaceuticals Product and Services
2.2.4 MR Solutions Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Scanco Medical
2.3.1 Scanco Medical Details
2.3.2 Scanco Medical Major Business
2.3.3 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Product and Services
2.3.4 Scanco Medical Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 PerkinElmer
2.4.1 PerkinElmer Details
2.4.2 PerkinElmer Major Business
2.4.3 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Product and Services
2.4.4 PerkinElmer Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Trifoil Imaging
2.5.1 Trifoil Imaging Details
2.5.2 Trifoil Imaging Major Business
2.5.3 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Product and Services
2.5.4 Trifoil Imaging Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mediso
2.6.1 Mediso Details
2.6.2 Mediso Major Business
2.6.3 Mediso Preclinical Tomography System for Biopharmaceuticals Product and Services
2.6.4 Mediso Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sedecal
2.7.1 Sedecal Details
2.7.2 Sedecal Major Business
2.7.3 Sedecal Preclinical Tomography System for Biopharmaceuticals Product and Services
2.7.4 Sedecal Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 MILabs
2.8.1 MILabs Details
2.8.2 MILabs Major Business
2.8.3 MILabs Preclinical Tomography System for Biopharmaceuticals Product and Services
2.8.4 MILabs Preclinical Tomography System for Biopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Preclinical Tomography System for Biopharmaceuticals Breakdown Data by Manufacturer
3.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Preclinical Tomography System for Biopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Preclinical Tomography System for Biopharmaceuticals Manufacturer Market Share in 2021
3.4.2 Top 6 Preclinical Tomography System for Biopharmaceuticals Manufacturer Market Share in 2021
3.5 Global Preclinical Tomography System for Biopharmaceuticals Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Preclinical Tomography System for Biopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Preclinical Tomography System for Biopharmaceuticals Market Size by Region
4.1.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Region (2017-2028)
4.1.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2028)
4.2 North America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.3 Europe Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.4 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.5 South America Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
4.6 Middle East and Africa Preclinical Tomography System for Biopharmaceuticals Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Type (2017-2028)
5.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Type (2017-2028)
5.3 Global Preclinical Tomography System for Biopharmaceuticals Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Application (2017-2028)
6.2 Global Preclinical Tomography System for Biopharmaceuticals Revenue by Application (2017-2028)
6.3 Global Preclinical Tomography System for Biopharmaceuticals Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
7.2 North America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
7.3 North America Preclinical Tomography System for Biopharmaceuticals Market Size by Country
7.3.1 North America Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
7.3.2 North America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
8.2 Europe Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
8.3 Europe Preclinical Tomography System for Biopharmaceuticals Market Size by Country
8.3.1 Europe Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
8.3.2 Europe Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
9.2 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
9.3 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Preclinical Tomography System for Biopharmaceuticals Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
10.2 South America Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
10.3 South America Preclinical Tomography System for Biopharmaceuticals Market Size by Country
10.3.1 South America Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
10.3.2 South America Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Type (2017-2028)
11.2 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales by Application (2017-2028)
11.3 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Preclinical Tomography System for Biopharmaceuticals Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Preclinical Tomography System for Biopharmaceuticals and Key Manufacturers
12.2 Manufacturing Costs Percentage of Preclinical Tomography System for Biopharmaceuticals
12.3 Preclinical Tomography System for Biopharmaceuticals Production Process
12.4 Preclinical Tomography System for Biopharmaceuticals Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Preclinical Tomography System for Biopharmaceuticals Typical Distributors
13.3 Preclinical Tomography System for Biopharmaceuticals Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---